Leading science, pioneering therapies

CRM Publications

Found 42 results
Filters: Keyword is Rats, Sprague-Dawley  [Clear All Filters]
2003
Chandran S, Kato H, Gerreli D, Compston A, Svendsen CN, Allen ND.  2003.  FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway.Development. 130(26):6599-609.
Buehr M, Nichols J, Stenhouse FH, Mountford P, Greenhalgh CJ, Kantachuvesiri S, Brooker G, Mullins JJ, Smith AG.  2003.  Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines.Biol Reprod. 68(1):222-9.
2002
Golde S, Chandran S, Brown GC, Compston A.  2002.  Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression.J Neurochem. 82(2):269-82.
1999
Brosnan MJ, Devlin AM, Clark JS, Mullins JJ, Dominiczak AF.  1999.  Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.Am J Hypertens. 12(7):724-31.
1997
Ahlgren SC, Wallace H, Bishop J, Neophytou C, Raff MC.  1997.  Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro.Mol Cell Neurosci. 9(5-6):420-32.
Neophytou C, Vernallis AB, Smith A, Raff MC.  1997.  Müller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rod stage of development.Development. 124(12):2345-54.
Mitchell KD, Jacinto SM, Mullins JJ.  1997.  Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.Am J Physiol. 273(2 Pt 2):F246-53.
1995
Véniant M, Whitworth CE, Ménard J, Sharp MG, Gonzales MF, Bruneval P, Mullins JJ.  1995.  Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.Am J Hypertens. 8(12 Pt 1):1167-76.
Whitworth CE, Veniant MM, Firth JD, Cumming AD, Mullins JJ.  1995.  Endothelin in the kidney in malignant phase hypertension.Hypertension. 26(6 Pt 1):925-31.
Whitworth CE, Fleming S, Kotelevtsev Y, Manson L, Brooker GA, Cumming AD, Mullins JJ.  1995.  A genetic model of malignant phase hypertension in rats.Kidney Int. 47(2):529-35.
Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T.  1995.  Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.Br J Pharmacol. 116(4):2237-44.
Selig DK, Hjelmstad GO, Herron CE, Nicoll RA, Malenka RC.  1995.  Independent mechanisms for long-term depression of AMPA and NMDA responses.Neuron. 15(2):417-26.
1994
Herron CE, Malenka RC.  1994.  Activity-dependent enhancement of synaptic transmission in hippocampal slices treated with the phosphatase inhibitor calyculin A.J Neurosci. 14(10):6013-20.
Whitworth CE, Fleming S, Cumming AD, Morton JJ, Burns NJ, Williams BC, Mullins JJ.  1994.  Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats.Kidney Int. 46(6):1528-32.
Mullins JJ, Mullins LJ.  1994.  Transgenes, hypotheses, and hypertension.Hypertension. 23(4):428-30.
1993
Mulkey RM, Herron CE, Malenka RC.  1993.  An essential role for protein phosphatases in hippocampal long-term depression.Science. 261(5124):1051-5.

Pages